The current study demonstrates that CD63 is capable of transducing signals in melanoma cells that requires extracellular Ca2+ and is inhibited by the protein kinase C inhibitor chelerythrine, and that CD63 is associated with serine protein kinase activity in melanoma cells. This evidence concerns the gene CD63 and melanoma.